Efficacy and Safety of Rezivertinib (BPI-7711) in Patients with Locally Advanced or Metastatic/Recurrent <i>EGFR</i> T790M Mutated NSCLC: A Phase IIb Study Yuankai Shi , Shiman Wu , Ke Wang , Shundong Cang , Wenxiu Yao , Yun Fan , Lin Wu , Meijuan Huang , Xingya Li , Yueyin Pan , Zhixiong Yang , Bo Zhu , Gongyan Chen , Jianhua Shi , Meili Sun , Jian Fang , Lijun Wang , Zhaohong Chen , Chunling Liu , Jingzhang Li , Jiwei Liu , Shenghua Sun , Yanqiu Zhao , Yanzhen Guo , Zili Meng , Zhefeng Liu , Zhigang Han , Hong Lu , Rui Ma , Shen Hu , Guofang Zhao , Zheng Liu , Congying Xie , Diansheng Zhong , Hui Zhao , Huiqing Yu , Longzhen Zhang , Minghong Bi , Shanyong Yi , Shuliang Guo , Tienan Yi , Wen Li , Yingcheng Lin , Yongqian Shu , Zhendong Chen , Zhongliang Guo , Michael Greco , Tingting Wang , Haijiao Shen SSRN Electronic Journal(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper